nav menu
close nav
background
background

NEWS

15 February 2022

Abstract P4-02-01: Targeting insulin receptor in estrogen receptor positive breast cancer

Abstract P4-02-01: Targeting insulin receptor in estrogen receptor positive breast cancer

8 February 2022

Easier-To-Produce Room Temperature Covid Shot Shows Promise In Early Clinical Trials

Easier-To-Produce Room Temperature Covid Shot Shows Promise In Early Clinical Trials

8 February 2022

Akston Biosciences Announces Publication in Vaccine of Positive Data for a Room Temperature Protein Subunit COVID-19 Vaccine

Akston Biosciences Announces Publication in Vaccine of Positive Data for a Room Temperature Protein Subunit COVID-19 Vaccine

6 January 2022

Akston Biosciences seeks USD 10m–25m raise, plans for further COVID-19 vaccine booster trials

Akston Biosciences seeks USD 10m–25m raise, plans for further COVID-19 vaccine booster trials

21 December 2021

Akston Biosciences Announces Positive Top-Line Data from Phase II Study of COVID-19 Vaccine in the Netherlands 

Akston Biosciences Announces Positive Top-Line Data from Phase II Study of COVID-19 Vaccine in the Netherlands 

2 December 2021

What will tomorrow’s Covid-19 vaccines be like?

What will tomorrow’s Covid-19 vaccines be like?

19 November 2021

Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine

Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine

11 November 2021

‘Looking forward to second-gen vaccines,’ says WHO chief: From nasal sprays to multivariant jabs, vaccines in development spur hope of ending the pandemic

‘Looking forward to second-gen vaccines,’ says WHO chief: From nasal sprays to multivariant jabs, vaccines in development spur hope of ending the pandemic

1 November 2021

Vaccinating the World: the effort to get COVID vaccines to everyone

Vaccinating the World: the effort to get COVID vaccines to everyone

16 October 2021

Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452